Kryo Pharmaceuticals Private Limited
About Kryo Pharmaceuticals Private Limited
Data last updated:
Kryo Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 29 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2019PTC356793. Its GSTIN is 07AAHCK8535C1ZJ (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Farah Khan and Zaid Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 175 Gali No 1 GF Sangam Vihar Near S Vihar, Delhi, India – 110062.
As per the financials filed for FY 2024, the company reported a revenue of ₹40.51 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹5.68 Lakh (net margin -14%) and EBITDA of -₹5.65 Lakh (EBITDA margin -14%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years.
The company is associated with 1 brand: Dilli 7 Pharmacy.
Company details
Contact details
Kryo Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressD – 175 Gali No 1 GF Sangam Vihar Near S Vihar, Delhi, India – 110062
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Kryo Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Kryo Pharmaceuticals operates one associated brand: Dilli 7 Pharmacy. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides a digital platform for convenient purchasing and delivery of medicines. | dilli7pharmacy.com |
Business activity
The main business activity of Kryo Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Kryo Pharmaceuticals Private Limited, buy the company report.
Financials of Kryo Pharmaceuticals Private Limited
FY 2025 filings availableKryo Pharmaceuticals Private Limited reported revenue of ₹40.51 Lakh (up 215% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over three years, including 215% growth in the latest year. EBITDA fell 131% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -14% | ||||
| Net Profit Margin | -14% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kryo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kryo Pharmaceuticals Private Limited
Kryo Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Farah Khan | Director | 25 May 2020 | 6 Years 4 Months | Current |
| Zaid Khan | Director | 26 Aug 2021 | 5 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Kryo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kryo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kryo Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCK8535C1ZJ | Delhi | Active | 13 Mar 2020 |
To see the full GST registrations and return filing status of Kryo Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kryo Pharmaceuticals Private Limited has 8 board changes on record since 2019: 5 appointments and 3 cessations. The latest: Naved Ahmed ceased to be Director on 09 Sep 2021.
Frequently asked questions
Kryo Pharmaceuticals is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 29 October 2019 (7+ years old) and is registered under CIN U51909DL2019PTC356793.
Kryo Pharmaceuticals has 2 current directors:
- Farah Khan - Director
- Zaid Khan - Director
The latest financial statements of Kryo Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Kryo Pharmaceuticals is 07AAHCK8535C1ZJ, registered in Delhi.
The CIN (Corporate Identification Number) of Kryo Pharmaceuticals is U51909DL2019PTC356793. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kryo Pharmaceuticals was incorporated on 29 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Naved Ahmed ceased to be Director on 09 Sep 2021. Zaid Khan was appointed as Director on 26 Aug 2021. Abdul Rahman ceased to be Director on 24 Jul 2021. Kryo Pharmaceuticals has 8 board changes on record in total.
The registered office of Kryo Pharmaceuticals is at D – 175 Gali No 1 GF Sangam Vihar Near S Vihar, Delhi, India – 110062.
Kryo Pharmaceuticals operates in the trading industry, in the specialty segment.
Kryo Pharmaceuticals has 1 associated brand: Dilli 7 Pharmacy.